Problem statement: Answer the multiple choice question.
Question: Which drug exhibits a -2.850\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a: Cc1cc(C(=O)OCC(=O)Nc2ccccc2[N+](=O)[O-])c2ccccc2n1
b: Cc1nc(SCc2ccccc2F)c2oc3ccccc3c2n1
c: O=C(CSc1nnc(-c2ccccc2)c2ccccc12)NCCN1C(=O)CSC1=O
Answer: c. O=C(CSc1nnc(-c2ccccc2)c2ccccc12)NCCN1C(=O)CSC1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
O=C(CSc1nnc(-c2ccccc2)c2ccccc12)NCCN1C(=O)CSC1=O
O=C(CSc1nnc(-c2ccccc2)c2ccccc12)NCCN1C(=O)CSC1=O
N-[2-(2,4-dioxo-1,3-thiazolidin-3-yl)ethyl]-2-(4-phenylphthalazin-1-yl)sulfanylacetamide